Developer docs
API playgroundTry for free, no card

Search company profiles

Schweiger Dermatology

Full company profile

uuid0000zmc

Namestring
Schweiger Dermatology
Legal namestring
Schweiger Dermatology Group
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Schweiger Dermatology Group is a privately held, PE-backed dermatology practice platform founded in 2010 by Dr. Eric Schweiger in New York to address long wait times for dermatology appointments. The company operates 160+ office locations across 9 states (New York, New Jersey, Pennsylvania, Connecticut, Florida, Illinois, Minnesota, Missouri, and California) staffed by 600+ providers, having served more than 2 million patients historically. Its service mix spans medical dermatology (acne, eczema, psoriasis, skin cancer screening and Mohs surgery), cosmetic dermatology (Botox, dermal fillers, laser and light treatments, chemical peels, microneedling, hair restoration, Ultherapy), surgical dermatology, and allergy and immunology services delivered through a dedicated Schweiger Allergy division launched in 2023.

The underlying technology stack is conventional practice infrastructure rather than a proprietary platform: the EMA (ema.md) patient portal and EHR for medical records, scheduling, and provider communication, Zocdoc integration for online booking, a Workday-based careers and recruiting portal, a Smartsheet-managed APP program application flow, OneTrust for CCPA consent, Google reCAPTCHA on public forms, PatientBillHelp.com for billing, and a separate Shop Schweiger e-commerce site for physician-dispensed skincare. The clinical differentiation rests on a proprietary Advanced Practice Provider (APP) Training Program in both dermatology and allergy, an in-house dermatopathology lab under a Laboratory Director, a dedicated Clinical Research Department running Phase 4 trials in psoriasis, vitiligo, atopic dermatitis, alopecia areata, and other indications (with Dr. David Goldberg as Director of Clinical Research), and an Ambulatory Surgery Center. The company also operates a centralized contracting and credentialing function supporting 70+ Castle Connolly Top Doctors (2026) and a #2 national ranking by Castle Connolly.

Revenue is generated through multiple streams: insurance-billed medical dermatology (subscription/recurring), cash-pay cosmetic procedures (one-time), insurance-billed allergy services with recurring immunotherapy (subscription/recurring), physician-dispensed skincare e-commerce (hardware/product sales), and in-house laboratory fees (professional services). Patient acquisition is direct-to-consumer via online booking (Zocdoc), phone (844-DERM-DOC), SMS scheduling, walk-ins, and telehealth, with financing through CareCredit for out-of-pocket costs above $250. The go-to-market combines consumer marketing (SEO, content, reviews, press coverage in Vogue, Allure, Forbes, GQ, and the New York Post) with a B2B channel targeting independent dermatology practices for acquisition—a roll-up strategy funded by $35M from LLR Partners (2016), $100M from LNK Partners (2020), and additional debt facilities, and executed through 20+ completed acquisitions including The Derm Group (2021, 40 providers), United Skin Specialists (2024, Midwest platform), Lake Dermatology (2023, first Southeast entry), and Allergy & Asthma Care of New York (2023, allergy vertical launch).

Short descriptiontext

Schweiger Dermatology Group is a PE-backed dermatology practice platform operating 160+ locations across 9 states with 600+ providers, delivering integrated medical, cosmetic, surgical, and allergy dermatology services to a base of more than 2 million patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical dermatology services, cosmetic dermatology treatments, allergy and immunology care, surgical dermatology Mohs, skin cancer treatment
Industry5 codes
PRIMARYHLAKACAA
General & Medical Dermatology
SECONDARYHLAKACAG
Procedural Dermatology (Office-Based Surgery)
SECONDARYHLAKACAD
Mohs Surgery & Skin Cancer (Dermatologic Oncology)
SECONDARYHLAKACAK
Contact Dermatitis & Patch Testing
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
NAICS code1 code
  • Offices of All Other Health Practitioners62139
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Medical Laboratories8071
Product category
Dermatology Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Medical Dermatology Services
TypeSubscription Recurring
Description

Insurance-billed medical dermatology services including skin cancer treatments, acne treatment, eczema, psoriasis, and general dermatology conditions.

schweigerderm.com
2Cosmetic Dermatology Services
TypeOne Time License
Description

Elective cosmetic procedures including Botox, dermal fillers, laser treatments, chemical peels - not billed through insurance.

schweigerderm.com
3Allergy Services
TypeSubscription Recurring
Description

Allergy testing, immunotherapy, and asthma treatments through Schweiger Allergy.

schweigerderm.com
4Skincare Products
TypeHardware Sales
Description

Physician-dispensed skincare products through shop.schweigerderm.com

schweigerderm.com
5Laboratory Services
TypeProfessional Services
Description

In-house laboratory processing for biopsies and excisions. $100 charge for lab costs if no insurance.

schweigerderm.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details3 tiers
1Insurance-covered medical visits
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Most insurance plans accepted including Aetna, Cigna, Blue Cross Blue Shield, UnitedHealthcare, Medicare, and many others. Co-pay, co-insurance, and deductible structures vary by plan.

schweigerderm.com
2Cosmetic elective procedures
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Cosmetic procedures are elective and not billed through insurance. $125 deposit may be required at scheduling. Financing available through Care Credit.

schweigerderm.com
3Laboratory costs for uninsured
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$100 charge for all lab costs if no insurance coverage.

schweigerderm.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1Schweiger Allergy
Description

Allergy and immunology services division of Schweiger Dermatology Group offering testing, treatment, and immunotherapy for environmental and food allergies

schweigerderm.com
Core offering1 text field

Schweiger Dermatology Group is a multi-location dermatology practice that delivers medical, cosmetic, surgical, and allergy/immunology care through 160+ office locations staffed by 600+ providers. Services include skin cancer screening and treatment, Mohs surgery, acne, eczema, psoriasis, Botox and dermal fillers, laser treatments, allergy testing and immunotherapy, and clinical trial participation, with most major insurance plans accepted.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 2 million patients served
+3 more records
Product overview1 text field

Schweiger Dermatology Group operates as a multi-location dermatology practice offering integrated medical, cosmetic, and surgical dermatology services alongside dedicated allergy care through Schweiger Allergy. The company provides a comprehensive suite of services including medical dermatology (acne, eczema, psoriasis, skin cancer screening/treatment), cosmetic dermatology (Botox, fillers, laser treatments, chemical peels), surgical procedures including Mohs surgery, and clinical trials for various skin conditions. The organization also offers an Advanced Practice Provider training program and a dedicated allergy training program. Services are delivered across 160+ locations in 10 states through a network of 600+ providers serving approximately 2 million patients, with patient support tools including an online portal, e-commerce shop for skincare products, and multiple insurance and financing options.

Product and service6 records
1Medical Dermatology
CategoryMedical dermatology services
2Cosmetic Dermatology
CategoryCosmetic dermatology services
3Surgical Dermatology and Mohs Surgery
CategorySurgical dermatology services
4Schweiger Allergy Services
CategoryAllergy and immunology services
5Skincare Products (Shop Schweiger)
CategorySkincare product sales
6Clinical Trials and Research
CategoryClinical research services
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-27
Description

Schweiger Dermatology selected as key partner for the Aesthetics Leadership with Obagi's Hyaluronic Acid (ALOHA) Program to generate real-world evidence for the Obagi saypha MagIQ injectable product. Collaboration includes Phase 4 clinical study led by Dr. David Goldberg at Hackensack location and real-world evaluation program at select Schweiger aesthetic locations. Initial activities expected to begin in early 2026.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clinical collaboration where Schweiger principal investigators presented 12-month clinical data for Cutera's AviClear laser treatment at Fall Clinical Dermatology Conference. Dr. David Goldberg serves as Director of Clinical Research.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

New Jersey-based dermatology practice acquired by Schweiger in October 2021. Pre-acquisition, it operated as a comparable single-state independent dermatology group with medical and surgical services.

TypeDirect peer
Description

US Dermatology Partners is the largest PE-backed dermatology consolidator in the US, with 100+ locations across multiple states. It is the most direct comparator to Schweiger's acquisition-driven, multi-specialty dermatology platform.

TypeDirect peer
Description

One of the largest dermatology practices in the US, with locations across Florida and the Southeast offering medical, surgical, and cosmetic dermatology. Operates as a PE-backed platform competing in the same consolidation category.

4QualDerm Partners
TypeDirect peer
Description

PE-backed dermatology and skin care consolidator with 50+ locations across the eastern US. Operates a similar acquisition-based multi-state dermatology platform serving insured medical and cash-pay aesthetic markets.

5Forefront Dermatology
TypeDirect peer
Description

Large Midwest-anchored dermatology practice network with 100+ locations across multiple states. Provides full-service medical, surgical, and cosmetic dermatology under a multi-site, multi-state operating model.

TypeDirect peer
Description

Mid-Atlantic dermatology platform operating 100+ locations with medical, surgical, and cosmetic services. Following a similar acquisition strategy across the Northeast and Southeast US.

TypeDirect peer
Description

PE-backed dermatology network with strong Midwest presence acquired by Sun Capital in 2023. Comparable multi-state dermatology rollup with medical, surgical, and aesthetic service lines.

TypeDirect peer
Description

Florida-based dermatology practice network offering medical, surgical, and cosmetic services. A regional consolidator with a comparable service mix; previously supported by private equity.

TypeBroad incumbent
Description

Long-established independent-affiliated multi-location dermatology groups operating across the US. Larger and more fragmented group practices offering the same core medical, surgical, and cosmetic dermatology services.

TypeOthers
Description

Global medical-grade skincare company. Partnered with Schweiger (Feb 2026) for the ALOHA Program; comparable as a dermatology-aligned products and aesthetics brand serving the same patient population.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration9 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries8 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A10 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Schweiger Dermatology

Dermatology Servicesschweigerderm.com

Schweiger Dermatology Group is a PE-backed dermatology practice platform operating 160+ locations across 9 states with 600+ providers, delivering integrated medical, cosmetic, surgical, and allergy dermatology services to a base of more than 2 million patients.

What Schweiger Dermatology does

Schweiger Dermatology Group is a privately held, PE-backed dermatology practice platform founded in 2010 by Dr. Eric Schweiger in New York to address long wait times for dermatology appointments. The company operates 160+ office locations across 9 states (New York, New Jersey, Pennsylvania, Connecticut, Florida, Illinois, Minnesota, Missouri, and California) staffed by 600+ providers, having served more than 2 million patients historically. Its service mix spans medical dermatology (acne, eczema, psoriasis, skin cancer screening and Mohs surgery), cosmetic dermatology (Botox, dermal fillers, laser and light treatments, chemical peels, microneedling, hair restoration, Ultherapy), surgical dermatology, and allergy and immunology services delivered through a dedicated Schweiger Allergy division launched in 2023.

The underlying technology stack is conventional practice infrastructure rather than a proprietary platform: the EMA (ema.md) patient portal and EHR for medical records, scheduling, and provider communication, Zocdoc integration for online booking, a Workday-based careers and recruiting portal, a Smartsheet-managed APP program application flow, OneTrust for CCPA consent, Google reCAPTCHA on public forms, PatientBillHelp.com for billing, and a separate Shop Schweiger e-commerce site for physician-dispensed skincare. The clinical differentiation rests on a proprietary Advanced Practice Provider (APP) Training Program in both dermatology and allergy, an in-house dermatopathology lab under a Laboratory Director, a dedicated Clinical Research Department running Phase 4 trials in psoriasis, vitiligo, atopic dermatitis, alopecia areata, and other indications (with Dr. David Goldberg as Director of Clinical Research), and an Ambulatory Surgery Center. The company also operates a centralized contracting and credentialing function supporting 70+ Castle Connolly Top Doctors (2026) and a #2 national ranking by Castle Connolly.

Revenue is generated through multiple streams: insurance-billed medical dermatology (subscription/recurring), cash-pay cosmetic procedures (one-time), insurance-billed allergy services with recurring immunotherapy (subscription/recurring), physician-dispensed skincare e-commerce (hardware/product sales), and in-house laboratory fees (professional services). Patient acquisition is direct-to-consumer via online booking (Zocdoc), phone (844-DERM-DOC), SMS scheduling, walk-ins, and telehealth, with financing through CareCredit for out-of-pocket costs above $250. The go-to-market combines consumer marketing (SEO, content, reviews, press coverage in Vogue, Allure, Forbes, GQ, and the New York Post) with a B2B channel targeting independent dermatology practices for acquisition—a roll-up strategy funded by $35M from LLR Partners (2016), $100M from LNK Partners (2020), and additional debt facilities, and executed through 20+ completed acquisitions including The Derm Group (2021, 40 providers), United Skin Specialists (2024, Midwest platform), Lake Dermatology (2023, first Southeast entry), and Allergy & Asthma Care of New York (2023, allergy vertical launch).

Schweiger Dermatology firmographics

Firmographics
Name
Schweiger Dermatology
Legal name
Schweiger Dermatology Group
Website
https://schweigerderm.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Schweiger Dermatology Group is a PE-backed dermatology practice platform operating 160+ locations across 9 states with 600+ providers, delivering integrated medical, cosmetic, surgical, and allergy dermatology services to a base of more than 2 million patients.
Ownership category
akta.pro rank

Schweiger Dermatology industry classification

Industry
Product category
Dermatology Services
NAICS
Offices of All Other Health Practitioners (62139)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAKACAA
General & Medical Dermatology
SECONDARYHLAKACAG
Procedural Dermatology (Office-Based Surgery)
SECONDARYHLAKACAD
Mohs Surgery & Skin Cancer (Dermatologic Oncology)
SECONDARYHLAKACAK
Contact Dermatitis & Patch Testing
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare

Keywords

  • Medical dermatology services
  • Cosmetic dermatology treatments
  • Allergy and immunology care
  • Surgical dermatology Mohs
  • Skin cancer treatment

Where Schweiger Dermatology is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices9 records

Markets served

Schweiger Dermatology business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Medical Dermatology Services: Insurance-billed medical dermatology services including skin cancer treatments, acne treatment, eczema, psoriasis, and general dermatology conditions.
  2. Cosmetic Dermatology Services: Elective cosmetic procedures including Botox, dermal fillers, laser treatments, chemical peels - not billed through insurance.
  3. Allergy Services: Allergy testing, immunotherapy, and asthma treatments through Schweiger Allergy.
  4. Skincare Products: Physician-dispensed skincare products through shop.schweigerderm.com
  5. Laboratory Services: In-house laboratory processing for biopsies and excisions. $100 charge for lab costs if no insurance.

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goInsurance-covered medical visits
One time/ perpetual licensePay-as-you-goCosmetic elective procedures
Unit PricingPay-as-you-goLaboratory costs for uninsured

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Schweiger Dermatology product offering

Product offering

Core offering

Schweiger Dermatology Group is a multi-location dermatology practice that delivers medical, cosmetic, surgical, and allergy/immunology care through 160+ office locations staffed by 600+ providers. Services include skin cancer screening and treatment, Mohs surgery, acne, eczema, psoriasis, Botox and dermal fillers, laser treatments, allergy testing and immunotherapy, and clinical trial participation, with most major insurance plans accepted.

Product overview

Schweiger Dermatology Group operates as a multi-location dermatology practice offering integrated medical, cosmetic, and surgical dermatology services alongside dedicated allergy care through Schweiger Allergy. The company provides a comprehensive suite of services including medical dermatology (acne, eczema, psoriasis, skin cancer screening/treatment), cosmetic dermatology (Botox, fillers, laser treatments, chemical peels), surgical procedures including Mohs surgery, and clinical trials for various skin conditions. The organization also offers an Advanced Practice Provider training program and a dedicated allergy training program. Services are delivered across 160+ locations in 10 states through a network of 600+ providers serving approximately 2 million patients, with patient support tools including an online portal, e-commerce shop for skincare products, and multiple insurance and financing options.

Differentiator

Problem solved

Functional benefit

Brands

  • Schweiger Allergy: Allergy and immunology services division of Schweiger Dermatology Group offering testing, treatment, and immunotherapy for environmental and food allergies

Products and services

  • Medical Dermatology
  • Cosmetic Dermatology
  • Surgical Dermatology and Mohs Surgery
  • Schweiger Allergy Services
  • Skincare Products (Shop Schweiger)
  • Clinical Trials and Research

Quantifiable outcome

  • Over 2 million patients served
  • +3 more outcomes

Companies that use Schweiger Dermatology

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles2 records

Schweiger Dermatology technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration9 records

Feature3 records

Schweiger Dermatology partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • Obagi MedicalcoreStrategic or Co-development Partner · 27 February 2026Schweiger Dermatology selected as key partner for the Aesthetics Leadership with Obagi's Hyaluronic Acid (ALOHA) Program to generate real-world evidence for the Obagi saypha MagIQ injectable product. Collaboration includes Phase 4 clinical study led by Dr. David Goldberg at Hackensack location and real-world evaluation program at select Schweiger aesthetic locations. Initial activities expected to begin in early 2026.
  • CuteraminorStrategic or Co-development PartnerClinical collaboration where Schweiger principal investigators presented 12-month clinical data for Cutera's AviClear laser treatment at Fall Clinical Dermatology Conference. Dr. David Goldberg serves as Director of Clinical Research.

Scale indicators10 records

Recent moves6 records

Expansion highlights2 records

Schweiger Dermatology competitors and assessment

Company assessment

Others

  • The Derm Group: New Jersey-based dermatology practice acquired by Schweiger in October 2021. Pre-acquisition, it operated as a comparable single-state independent dermatology group with medical and surgical services.
  • Obagi Medical: Global medical-grade skincare company. Partnered with Schweiger (Feb 2026) for the ALOHA Program; comparable as a dermatology-aligned products and aesthetics brand serving the same patient population.

Direct peers

  • US Dermatology Partners: US Dermatology Partners is the largest PE-backed dermatology consolidator in the US, with 100+ locations across multiple states. It is the most direct comparator to Schweiger's acquisition-driven, multi-specialty dermatology platform.
  • Advanced Dermatology and Cosmetic Surgery: One of the largest dermatology practices in the US, with locations across Florida and the Southeast offering medical, surgical, and cosmetic dermatology. Operates as a PE-backed platform competing in the same consolidation category.
  • QualDerm Partners: PE-backed dermatology and skin care consolidator with 50+ locations across the eastern US. Operates a similar acquisition-based multi-state dermatology platform serving insured medical and cash-pay aesthetic markets.
  • Forefront Dermatology: Large Midwest-anchored dermatology practice network with 100+ locations across multiple states. Provides full-service medical, surgical, and cosmetic dermatology under a multi-site, multi-state operating model.
  • Anne Arundel Dermatology: Mid-Atlantic dermatology platform operating 100+ locations with medical, surgical, and cosmetic services. Following a similar acquisition strategy across the Northeast and Southeast US.
  • Pinnacle Dermatology: PE-backed dermatology network with strong Midwest presence acquired by Sun Capital in 2023. Comparable multi-state dermatology rollup with medical, surgical, and aesthetic service lines.
  • Riverchase Dermatology: Florida-based dermatology practice network offering medical, surgical, and cosmetic services. A regional consolidator with a comparable service mix; previously supported by private equity.

Broad incumbents

  • Dermatology Associates: Long-established independent-affiliated multi-location dermatology groups operating across the US. Larger and more fragmented group practices offering the same core medical, surgical, and cosmetic dermatology services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Schweiger Dermatology social profiles

Digital presence

Schweiger Dermatology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Schweiger Dermatology leadership team

Management profile

Number of profiles

Profiles10 records

Schweiger Dermatology subsidiaries and ownership

Company hierarchy

Subsidiaries8 records

Schweiger Dermatology funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Schweiger Dermatology M&A and investment

M&A and investment

M&A10 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Schweiger Dermatology

What does Schweiger Dermatology do?

Schweiger Dermatology Group is a multi-location dermatology practice that delivers medical, cosmetic, surgical, and allergy/immunology care through 160+ office locations staffed by 600+ providers. Services include skin cancer screening and treatment, Mohs surgery, acne, eczema, psoriasis, Botox and dermal fillers, laser treatments, allergy testing and immunotherapy, and clinical trial participation, with most major insurance plans accepted.

Is Schweiger Dermatology a public or private company?

Schweiger Dermatology is a private company. It is classified as private equity controlled and is currently operating.

When was Schweiger Dermatology founded?

Schweiger Dermatology was founded in 2010. It employs 1,001 to 5,000 people.

Where is Schweiger Dermatology based?

Schweiger Dermatology is headquartered in New York, United States, in the North America region.

How does Schweiger Dermatology make money?

Five revenue lines are on record. Medical Dermatology Services are the primary driver. The others are cosmetic Dermatology Services, allergy Services, skincare Products and laboratory Services.

Who are Schweiger Dermatology's main competitors?

Others on record are The Derm Group and Obagi Medical. Direct peers are US Dermatology Partners, Advanced Dermatology and Cosmetic Surgery, QualDerm Partners, Forefront Dermatology, Anne Arundel Dermatology, Pinnacle Dermatology and Riverchase Dermatology. Dermatology Associates is listed as a broad incumbent.

Does Schweiger Dermatology have an API?

No public API is recorded for Schweiger Dermatology.

What industry is Schweiger Dermatology in?

Schweiger Dermatology's product category is Dermatology Services. Its primary akta.pro industry code is HLAKACAA, General & Medical Dermatology, with a secondary code of HLAKACAG, Procedural Dermatology (Office-Based Surgery). Its NAICS code is 62139 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireSchweiger Named to the 2026 Inc. 5000 List of Fastest-Growing Private Companies in America for the 10th Consecutive YearSchweiger Dermatology was named to the 2026 Inc. 5000 list of fastest-growing private companies, marking its 10th consecutive year on the list. The practice expanded through new offices, acquisitions, and same-week appointments, and serves patients across a national network.GlobeNewswireObagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™Obagi Medical and Schweiger Dermatology announced a partnership for the ALOHA program to generate real-world evidence for Obagi saypha MagIQ. The program includes a Phase 4 study and a real-world evaluation, with initial activities expected in early 2026. Schweiger will present findings at internal meetings and industry conferences.Stock TitanObagi Medical, Schweiger plan ALOHA MagIQ trialsObagi Medical announced Schweiger Dermatology as a key partner for the Aesthetics Leadership with Obagi's Hyaluronic Acid (ALOHA) Program to generate real-world evidence for the Obagi saypha MagIQ injectable product. Schweiger will conduct a Phase 4 clinical study and a real-world evaluation program across its national network of practices, with initial activities expected to begin in early 2026. The product, developed by Croma-Pharma GmbH using proprietary MACRO Core Technology, represents Obagi Medical's entry into injectable aesthetics built on a foundation of clinical evidence and integrated patient outcomes.GlobeNewswireObagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™Obagi Medical announced Schweiger Dermatology as a key partner for the Aesthetics Leadership with Obagi's Hyaluronic Acid (ALOHA) Program, which will generate real-world evidence for the Obagi® saypha® MagIQ™ injectable product. The collaboration includes a Phase 4 clinical study led by Dr. David Goldberg at the Hackensack location and a real-world evaluation program at select Schweiger aesthetic locations, with initial activities expected to begin in early 2026. The partnership aims to build a foundation of robust clinical evidence to support a differentiated launch strategy for the injectable product.PR NewswireSchweiger Dermatology Earns Top National and Regional Honors in Castle Connolly 2026 Accolades, With Over 70 Physicians Named Top DoctorsSchweiger Dermatology Group has been recognized in the Castle Connolly 2026 Accolades, ranking #2 Physician Practice in the Nation for Dermatology while securing #1 Dermatology Practice rankings in both New York and New Jersey. The practice also had over 70 physicians named Castle Connolly Top Doctors 2026, reflecting broad clinical excellence across its network.MorningstarSchweiger Dermatology Earns Top National and Regional Honors in Castle Connolly 2026 Accolades, With Over 70 Physicians Named Top DoctorsSchweiger Dermatology was recognized in the Castle Connolly 2026 Accolades, ranking #2 Physician Practice in the Nation for Dermatology and #1 Dermatology Practice in both New York and New Jersey. Over 70 of the practice's physicians were named Castle Connolly Top Doctors 2026, representing the top 7% of practicing physicians nationwide. The recognition highlights the practice's clinical excellence and expanded care offerings, including allergy services under Schweiger Allergy.ScoperesearchDermatology Valuation Multiples and M&A Trends 2025This industry report analyzes dermatology M&A trends and valuation multiples for 2025, noting that while deal activity slowed after the late-2010s explosion, consolidation continues through private equity-backed platforms and large dermatology management service organizations acquiring independent practices. EBITDA multiples range from 3-5x for solo practices to 12-15x for large integrated platforms, with key platforms including Epiphany Dermatology (39 deals), Pinnacle, Schweiger, and DermCare (each 20+ deals). The sector faces headwinds from regulatory scrutiny, reimbursement pressures, and competition for skilled dermatologists, though growth drivers include rising skin disorder prevalence, an aging population, and expanding aesthetic dermatology services.Daily Medical NewsPrivate equity in dermatology: Consolidation, modernization are on the horizonPrivate equity investments in U.S. dermatology practices have grown significantly since 2012, when firms like Audax and Varsity Healthcare Partners made early acquisitions, with the sector reaching approximately 35 PE-backed platforms across nearly 20 states by 2024. The industry is now shifting from initial platform acquisitions toward consolidation of larger PE-backed dermatology groups, exemplified by mergers such as QualDerm Partners with Pinnacle Dermatology and Schweiger Dermatology's acquisition of United Skin Specialists. Experts predict future growth will focus on integrating ancillary offerings like cosmetic dermatology and med spas, while government agencies including the FTC, DOJ, and HHS have launched inquiries into PE's expanding role in healthcare.PhysiciangrowthpartnersDermatology Private Equity: 2025 M&A Trends and OutlookAs of mid-2025, the dermatology sector has seen strong investor interest and a significant shift in M&A activity characterized by higher-quality transactions rather than sheer volume. Notable consolidations include Schweiger Dermatology's acquisition of California Skin Institute in 2025, while regulatory challenges at the state level present hurdles for future transactions. The continuing convergence of medical and cosmetic dermatology is drawing substantial investor attention.